Research Article | | Peer-Reviewed

Modeling Pulmonary Tuberculosis-Pneumonia Co-dynamics Incorporating Drug Resistance with Optimal Control

Received: 9 August 2025     Accepted: 21 August 2025     Published: 14 October 2025
Views:       Downloads:
Abstract

In this paper, a deterministic mathematical model illustrating the transmission dynamics of pulmonary tuberculosis and pneumonia co-infection is formulated, incorporating a drug-resistant strain. The model employs a Holling-type functional response to capture the impact of natural immunity on the progression from latent tuberculosis infection to active disease, as well as its role in controlling drug-resistant pulmonary tuberculosis-pneumonia co-infections. The model is extended to include optimal control theory, aimed at identifying strategies to minimize co-infections using prevention, screening of latently infected individuals, and treatment as control variables. Pontryagin’s Maximum Principle is applied to characterize the optimal control system. The resulting optimality system is then solved numerically using the Runge-Kutta-based forward-backward sweep method. Numerical simulations demonstrate that enhancing natural immunity among latently infected individuals significantly reduces the number of co-infected cases. The optimal control analysis indicates that the most effective strategy for controlling or reducing co-infections of drug-resistant tuberculosis and pneumonia is the combined optimization of infection prevention and screening of latently infected individuals. These findings underscore the importance of scaling up preventive measures against pulmonary tuberculosis and opportunistic pneumonia, alongside screening efforts, to effectively control co-infections. Additionally, the study recommends strengthening immunity among latently infected populations to further reduce the prevalence of co-infections.

Published in American Journal of Mathematical and Computer Modelling (Volume 10, Issue 4)
DOI 10.11648/j.ajmcm.20251004.12
Page(s) 121-144
Creative Commons

This is an Open Access article, distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution and reproduction in any medium or format, provided the original work is properly cited.

Copyright

Copyright © The Author(s), 2025. Published by Science Publishing Group

Keywords

Pulmonary Tuberculosis, Co-infection, Latently Infected, Natural Immunity, Drug-resistant Strain, Optimal Control

References
[1] World Health Organization. (2023). Global tuberculosis report 2023. Retrieved May 10, 2025, from
[2] World Health Organization. (2024). Tuberculosis fact sheet. Retrieved May 14, 2025, from
[3] Garcia, R. (2019). Community‐acquired pneumonia due to Streptococcus pneumoniae: when to consider coinfection with active pulmonary tuberculosis. Case Reports in Infectious Diseases, 2019(1), 4618413.
[4] Chavarría, A. G. C., & Quirós, L. B. (2018). Coinfection with Staphylococcus aureus community-acquired pneumonia and mycobacterium tuberculosis in a diabetic patient: a case report. Int Phys Med Rehab J, 3(3), 262-263.
[5] Yan, P., & Chowell, G. (2019). Quantitative methods for investigating infectious disease outbreaks (Vol. 70). Cham, Switzerland: Springer.
[6] Baguelin, M., Medley, G. F., Nightingale, E. S., O’Reilly, K. M., Rees, E. M., Waterlow, N. R., & Wagner, M. (2020). Tooling-up for infectious disease transmission modelling. Epidemics, 32, 100395.
[7] Kirimi, E. M., Muthuri, G. G., Ngari, C. G., & Karanja, S. (2024). Modeling the effects of vaccine efficacy and rate of vaccination on the transmission of pulmonary tuberculosis. Informatics in Medicine Unlocked, 46, 101470.
[8] Kirimi, E. M., Muthuri, G. G., Ngari, C. G., & Karanja, S. (2024). A Model for the Propagation and Control of Pulmonary Tuberculosis Disease in Kenya. Discrete Dynamics in Nature and Society, 2024(1), 5883142.
[9] Li, Q., & Wang, F. (2023). An epidemiological model for tuberculosis considering environmental transmission and reinfection. Mathematics, 11(11), 2423.
[10] Alfiniyah, C., Soetjianto, W. S. P. A., Aziz, M. H. N., & Ghadzi, S. M. B. S. (2024). Mathematical modeling and optimal control of tuberculosis spread among smokers with case detection. AIMS Mathematics, 9(11), 30472-30492.
[11] Xu, C., Cheng, K., Guo, S., Yuan, D., & Zhao, X. (2024). A dynamic model to study the potential TB infections and assessment of control strategies in China. arXiv preprint arXiv: 2401.12462.
[12] Ochieng, F. O. (2025). SEIRS model for TB transmission dynamics incorporating the environment and optimal control. BMC Infectious Diseases, 25(1), 490.
[13] Kang, T. L., Huo, H. F., & Xiang, H. (2024). Dynamics and optimal control of tuberculosis model with the combined effects of vaccination, treatment and contaminated environments. Mathematical Biosciences and Engineering, 21(4), 5308-5334.
[14] Otoo, D., Osman, S., Poku, S. A., & Donkoh, E. K. (2021). Dynamics of Tuberculosis (TB) with Drug Resistance to First‐Line Treatment and Leaky Vaccination: A Deterministic Modelling Perspective. Computational and Mathematical Methods in Medicine, 2021(1), 5593864.
[15] Mengistu, A. K., & Witbooi, P. J. (2023). Cost‐Effectiveness Analysis of the Optimal Control Strategies for Multidrug‐Resistant Tuberculosis Transmission in Ethiopia. International Journal of Differential Equations, 2023(1), 8822433.
[16] Aldila, D., Awdinda, N., Herdicho, F. F., Ndii, M. Z., & Chukwu, C. W. (2023). Optimal control of pneumonia transmission model with seasonal factor: learning from Jakarta incidence data. Heliyon, 9(7).
[17] Yano, T. K., & Bitok, J. (2022). Computational Modelling of Pneumonia Disease Transmission Dynamics with Optimal Control Analysis. Appl. Comput. Math, 11(5), 130-139.
[18] Swai, M. C., Shaban, N., & Marijani, T. (2021). Optimal control in two strain pneumonia transmission dynamics. Journal of Applied Mathematics, 2021(1), 8835918.
[19] Legesse, F. M., Rao, K. P., & Keno, T. D. (2023). Cost effectiveness and optimal control analysis for bimodal pneumonia dynamics with the effect of children's breastfeeding. Frontiers in Applied Mathematics and Statistics, 9, 1224891.
[20] World Health Organization. (2025). Integrated approach to tuberculosis and lung health: Policy brief. Geneva: World Health Organization. Licence: CC BY-NC-SA 3.0 IGO. Retrieved May 14, 2025, from
[21] Gweryina, R. I., Madubueze, C. E., Bajiya, V. P., & Esla, F. E. (2023). Modeling and analysis of tuberculosis and pneumonia co-infection dynamics with cost-effective strategies. Results in Control and Optimization, 10, 100210.
[22] Xiao- Ying, L., Hong- fei, D., Li-mei, Y., & Wei-min, L. (2016). Pulmonary tuberculosis and bacterial pneumonia co-infection; a clinical etiology investigation in China. Chinese Journal of Zoonoses, 30 (4), 364-372.
[23] Chandra, P., Grigsby, S. J., & Philips, J. A. (2022). Immune evasion and provocation by Mycobacterium tuberculosis. Nature Reviews Microbiology, 20(12), 750-766.
[24] Banerjee, S. (2021). Mathematical modeling: models, analysis and applications. Chapman and Hall/CRC.
[25] Khajanchi, S., Das, D. K., & Kar, T. K. (2018). Dynamics of tuberculosis transmission with exogenous reinfections and endogenous reactivation. Physica A: Statistical Mechanics and its Applications, 497, 52-71.
[26] Driessche, K., Khajanchi, S., & Kar, T. K. (2020). Transmission dynamics of tuberculosis with multiple re-infections. Chaos, Solitons & Fractals, 130, 109450.
[27] Khajanchi, S., Bera, S., & Roy, T. K. (2021). Mathematical analysis of the global dynamics of a HTLV-I infection model, considering the role of cytotoxic T-lymphocytes. Mathematics and Computers in Simulation, 180, 354-378.
[28] Chowell, G., & Kiskowski, M. (2016). Modeling ring-vaccination strategies to control Ebola virus disease epidemics. Mathematical and statistical modeling for emerging and re-emerging infectious diseases, 71-87.
[29] KNBS 2023. Statistical Abstract 2023. Nairobi, Kenya. Retrieved May 21, 2025, from
[30] National Tuberculosis, Leprosy and Lung Disease Program. National strategic plan for tuberculosis, leprosy and lung health 2019-2023. Ministry of Health, Kenya. Retrieved May 23, 2025, from
[31] National Tuberculosis, Leprosy and Lung Disease Program. 2022 Annual Report. Ministry of Health, Kenya. Retrieved May 21, 2025, from
[32] National Tuberculosis, Leprosy and Lung Disease Program. 2023 Annual Report. Ministry of Health, Kenya. Retrieved May 21, 2025, from https://nltp.co.ke/wp-content/uploads /2025/ 03/2023-Annual-Report.pdf
[33] Obsu, L. L. (2022). Optimal control analysis of a tuberculosis model. Journal of Biological Systems, 30(04), 837-855.
Cite This Article
  • APA Style

    Kirimi, E. M., Okelo, J., Kimathi, M., Ngure, K. (2025). Modeling Pulmonary Tuberculosis-Pneumonia Co-dynamics Incorporating Drug Resistance with Optimal Control. American Journal of Mathematical and Computer Modelling, 10(4), 121-144. https://doi.org/10.11648/j.ajmcm.20251004.12

    Copy | Download

    ACS Style

    Kirimi, E. M.; Okelo, J.; Kimathi, M.; Ngure, K. Modeling Pulmonary Tuberculosis-Pneumonia Co-dynamics Incorporating Drug Resistance with Optimal Control. Am. J. Math. Comput. Model. 2025, 10(4), 121-144. doi: 10.11648/j.ajmcm.20251004.12

    Copy | Download

    AMA Style

    Kirimi EM, Okelo J, Kimathi M, Ngure K. Modeling Pulmonary Tuberculosis-Pneumonia Co-dynamics Incorporating Drug Resistance with Optimal Control. Am J Math Comput Model. 2025;10(4):121-144. doi: 10.11648/j.ajmcm.20251004.12

    Copy | Download

  • @article{10.11648/j.ajmcm.20251004.12,
      author = {Erick Mutwiri Kirimi and Jeconiah Okelo and Mark Kimathi and Kenneth Ngure},
      title = {Modeling Pulmonary Tuberculosis-Pneumonia Co-dynamics Incorporating Drug Resistance with Optimal Control
    },
      journal = {American Journal of Mathematical and Computer Modelling},
      volume = {10},
      number = {4},
      pages = {121-144},
      doi = {10.11648/j.ajmcm.20251004.12},
      url = {https://doi.org/10.11648/j.ajmcm.20251004.12},
      eprint = {https://article.sciencepublishinggroup.com/pdf/10.11648.j.ajmcm.20251004.12},
      abstract = {In this paper, a deterministic mathematical model illustrating the transmission dynamics of pulmonary tuberculosis and pneumonia co-infection is formulated, incorporating a drug-resistant strain. The model employs a Holling-type functional response to capture the impact of natural immunity on the progression from latent tuberculosis infection to active disease, as well as its role in controlling drug-resistant pulmonary tuberculosis-pneumonia co-infections. The model is extended to include optimal control theory, aimed at identifying strategies to minimize co-infections using prevention, screening of latently infected individuals, and treatment as control variables. Pontryagin’s Maximum Principle is applied to characterize the optimal control system. The resulting optimality system is then solved numerically using the Runge-Kutta-based forward-backward sweep method. Numerical simulations demonstrate that enhancing natural immunity among latently infected individuals significantly reduces the number of co-infected cases. The optimal control analysis indicates that the most effective strategy for controlling or reducing co-infections of drug-resistant tuberculosis and pneumonia is the combined optimization of infection prevention and screening of latently infected individuals. These findings underscore the importance of scaling up preventive measures against pulmonary tuberculosis and opportunistic pneumonia, alongside screening efforts, to effectively control co-infections. Additionally, the study recommends strengthening immunity among latently infected populations to further reduce the prevalence of co-infections.
    },
     year = {2025}
    }
    

    Copy | Download

  • TY  - JOUR
    T1  - Modeling Pulmonary Tuberculosis-Pneumonia Co-dynamics Incorporating Drug Resistance with Optimal Control
    
    AU  - Erick Mutwiri Kirimi
    AU  - Jeconiah Okelo
    AU  - Mark Kimathi
    AU  - Kenneth Ngure
    Y1  - 2025/10/14
    PY  - 2025
    N1  - https://doi.org/10.11648/j.ajmcm.20251004.12
    DO  - 10.11648/j.ajmcm.20251004.12
    T2  - American Journal of Mathematical and Computer Modelling
    JF  - American Journal of Mathematical and Computer Modelling
    JO  - American Journal of Mathematical and Computer Modelling
    SP  - 121
    EP  - 144
    PB  - Science Publishing Group
    SN  - 2578-8280
    UR  - https://doi.org/10.11648/j.ajmcm.20251004.12
    AB  - In this paper, a deterministic mathematical model illustrating the transmission dynamics of pulmonary tuberculosis and pneumonia co-infection is formulated, incorporating a drug-resistant strain. The model employs a Holling-type functional response to capture the impact of natural immunity on the progression from latent tuberculosis infection to active disease, as well as its role in controlling drug-resistant pulmonary tuberculosis-pneumonia co-infections. The model is extended to include optimal control theory, aimed at identifying strategies to minimize co-infections using prevention, screening of latently infected individuals, and treatment as control variables. Pontryagin’s Maximum Principle is applied to characterize the optimal control system. The resulting optimality system is then solved numerically using the Runge-Kutta-based forward-backward sweep method. Numerical simulations demonstrate that enhancing natural immunity among latently infected individuals significantly reduces the number of co-infected cases. The optimal control analysis indicates that the most effective strategy for controlling or reducing co-infections of drug-resistant tuberculosis and pneumonia is the combined optimization of infection prevention and screening of latently infected individuals. These findings underscore the importance of scaling up preventive measures against pulmonary tuberculosis and opportunistic pneumonia, alongside screening efforts, to effectively control co-infections. Additionally, the study recommends strengthening immunity among latently infected populations to further reduce the prevalence of co-infections.
    
    VL  - 10
    IS  - 4
    ER  - 

    Copy | Download

Author Information
  • Sections